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Interventional Cardiology
STEMI Patients With Large Thrombus
Burden More Likely to Thrombose Stent
Investigators from the Thoraxcenter retrospectively reviewed over 800 acute ST-segment elevation myocardial infarction (STEMI) cases treated with drug-eluting
stents to determine the impact of thrombus burden (TB) on subsequent cases of stent
thrombosis (ST). Intracoronary TB was angiographically estimated and categorized as
large (LTB), defined as TB 2 vessel diameters, or small (STB). The cumulative
incidence of angiographic ST at 2 years was 8.2% for patients with LTB versus 1.3%
for those with STB. In this report, STEMI patients with LTB are at increased risk for
major adverse cardiac events, including increased short- and long-term risk for ST.
See page 573. See figure.
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Heart Failure
Spironolactone Improves LV Remodeling When Added to ARB
Adding an aldosterone blocker to an angiotensin-converting enzyme inhibitorseems to improve outcomes in severe heart failure; Chan and colleagues sought to
understand the utility of adding spironolactone to an angiotensin II receptor blocker
(ARB). Fifty-one systolic heart failure patients (left ventricular ejection fraction [LVEF]
40%) were randomly assigned to receive 1-year treatment of candesartan and
spironolactone (combination group) or candesartan and placebo (control group). The
combination group had substantial improvements in LVEF, left ventricular (LV)
end-diastolic volume index, and LV end-systolic volume index, whereas those in the
control group did not have significant changes. This small study suggests that adding
spironolactone to an ARB can significantly enhance LV reverse remodeling in patients
with systolic heart failure. See page 591. See figure.
Biomarkers
Novel Biomarker May Link Myocyte Stretch and Inflammation
Expression of the ST2 protein is enhanced by myocyte stretch, but it is also thereceptor for interleukin-33, a pro-inflammatory cytokine, suggesting that ST2
may represent a bridge between inflammatory and neurohormonal systems. Januzzi
and colleagues studied the utility of measuring ST2 in subjects presenting with acute
dyspnea. An elevated ST2 level was associated with a 5-fold increased risk of death at 1
year in all subjects and a 9-fold increased risk in those with acute heart failure. This
protein may serve as a useful adjunctive marker to brain natriuretic peptide levels to
further risk stratify patients presenting with dyspnea. See page 607.
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Heart Rhythm Disorders
Pacemaker Proarrhythmia? The Role of ICDs in Triggering Arrhythmias
Abrupt changes in ventricular cycle lengths (short-long-short [S-L-S]) may initiateventricular arrhythmias because both ventricular intervals and activation se-
quence are altered suddenly. Sweeney and colleagues studied stored electrograms from
over 1,300 episodes of ventricular tachycardia/ventricular fibrillation (VT/VF) in
patients with implantable cardioverter-defibrillators (ICDs). Pacing-facilitatedVT/VF
(pacing as part of the S-L-S) occurred in approximately 10%of cases, or 3%of patients,
with the frequency related to the pacing mode. A commentary by Fisher provides a
more accessible summary of this article and concludes that VT/VF in some ICD
patients may be initiated by S-L-S sequences that are actively facilitated by antibrady-
cardia pacing. See pages 614 and 623. See figure.
Autonomic Function
Central Blockade of Alpha Receptors
Ameliorates the Cardiovascular Effects of Cocaine
Menon and colleagues hypothesized that cocaine stimulates increases in heart rateand blood pressure via increases in sympathetic nerve activity (SNA). Dexme-
detomidine is a centrally acting 2 adrenergic receptor agonist, without peripheral
effects. Subjects were exposed to cocaine  dexmedetomidine. During intranasal
cocaine alone, SNA increased by 2-fold, mean arterial pressure by 14 mm Hg, and
heart rate by 18 beats/min. Dexmedetomidine abolished all 3 of these increases. This
study suggests that cocaine stimulates the cardiovascular system centrally, rather than
peripherally, and that dexmedetomidine may be an effective antidote to cocaine’s
sympathomimetic actions. See page 626.
